Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Vaccines|November 27, 2021
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer ModelOlga Trofimova, Ksenija Korotkaja, Dace Skrastina, et al.
Journal of Photochemistry and Photobiology|April 19, 2022
UV inactivation of Semliki Forest virus and bacteria by alternative light sourcesAtis Skudra, Gita Revalde, Anna Zajakina, et al.
BMC Cancer|June 22, 2014
High efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor modelAnna Zajakina, Jelena Vasilevska, Dmitry Zhulenkovs, et al.
Molecular Therapy. Oncology|February 2, 2026
Virus-based IFNγ gene delivery and photodynamic therapy cooperate to remodel the tumor microenvironment and suppress breast cancerKsenija Korotkaja, Zhanna Rudevica, Darija Lapina, et al.
Frontiers in Immunology|December 26, 2017
Generation and Functional In Vitro Analysis of Semliki Forest Virus Vectors Encoding TNF-α and IFN-γBaiba Kurena, Elisabeth Müller, Panagiotis F Christopoulos, et al.
Molecules (Basel, Switzerland)|April 14, 2026
Design, Synthesis, and Self-Assembly of Amphiphilic 1,4-Dihydropyridines Containing Branched Ester MoietiesDavis Lacis, Martins Rucins, Nadiia Pikun, et al.
Journal of Medical Virology|July 4, 2007
Proteasomal degradation of core protein variants from chronic hepatitis B patientsSabine Braun, Anna Zajakina, Jekaterina Aleksejeva, et al.
Cancer Biology & Therapy|September 17, 2016
Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironmentJelena Vasilevska, Gustavo Antonio De Souza, Maria Stensland, et al.
Vaccines|March 28, 2024
Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived PeptidesIvars Petrovskis, Dace Skrastina, Juris Jansons, et al.
The Journal of General Virology|March 5, 2026
Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvantAndris Dislers, Olga Nilova, Juris Jansons, et al.
Pageof 3